SciClone Pharmaceuticals, Inc. (SCLN) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영.
SCLN 을(를) 보유 IPO 날짜 1992-03-17, 에 상장 NASDAQ.
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.
